Unusual presentation of syncytial variant of nodular sclerosis classical Hodgkin’s lymphoma presenting as unilateral lung mass in a 15-year-old child

2018 ◽  
Vol 57 (12) ◽  
pp. 1729-1732
Author(s):  
Ritesh Sachdev ◽  
Shalini Goel ◽  
Neha Rastogi ◽  
Satya Prakash Yadav ◽  
Ishani Mohapatra
2009 ◽  
Vol 101 (8) ◽  
pp. 1393-1401 ◽  
Author(s):  
A Birgersdotter ◽  
K R N Baumforth ◽  
A Porwit ◽  
J Sjöberg ◽  
W Wei ◽  
...  

2002 ◽  
Vol 13 (4) ◽  
pp. 637 ◽  
Author(s):  
C.T.A.M. Knibbeler-van Rossum ◽  
F.J.P. Peters ◽  
F.L.G. Erdkamp ◽  
L.P. Bos

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 3121-3121
Author(s):  
Alexander Claviez ◽  
Markus Tiemann ◽  
Heike Lueders ◽  
Reza Parwaresch ◽  
Guenther Schellong ◽  
...  

Abstract The prognostic significance of latent Epstein-Barr virus (EBV) infection in Hodgkin’s lymphoma (HL) is debated controversially. Especially in the pediatric age group, no conclusive data are available due to small series. 842 children and adolescents (55% male) with a median age of 13.7 years (range, 2–20) from consecutive pediatric DAL/GPOH multicenter treatment studies HD-90 and HD-95 were studied for the presence of latent EBV infection in Hodgkin and Reed-Sternberg cells by immunostaining against latent membrane protein 1 (LMP-1). Histology subtypes were as follows: nodular sclerosis (NSHL) 549, mixed cellularity (MCHL) 190, lymphocyte predominance (NLPHL) 90, lymphocyte depletion (LDHL) 6, lymphocyte-rich classical HL (LRCHL) 5, not specified 2. 88 patients had stage I, 470 had stage II, 172 had stage III and 112 had stage IV. B symptoms were present in 274 patients (33%). LMP status was compared with clinical parameters and established risk factors. A total of 263 patients (32%) were LMP positive. EBV infection correlated with gender (male 39% vs. female 23%; p<.001), histological subtype (MCHL 69% vs. NSHL 22% vs. NLPHL 6%; p<.001) and age (<10 years 67% vs ≥10 years 28%, p<.001. With a median follow-up of 4.9 years (0.3–12) 820 patients (97%) are alive. Probability of overall survival at 10 years (±SD) for EBV negative and positive patients was 98±1% and 95±1%, respectively (p=.017 by log-rank test). Probability of failure-free survival (FFS) in LMP positive and negative patients was 89±2% and 84±4%, respectively (p=.86). With respect to LMP status, a negative effect of latent EBV infection on overall survival became evident only for patients treated for advanced stages (p=.003), those with nodular sclerosis subtype Bennett II (p=.02) and B symptoms (p=.05). In a multivariate regression analysis, allocation to treatment group (RR=3.7) and LMP positivity (RR=3.01) were independent factors for overall survival and presence of B symptoms (RR=2.4) for FFS. Under current highly effective polychemotherapy with or without involved field radiotherapy in pediatric HL, latent EBV infection has no influence on FFS in univariate and multivariate analysis. LMP positivity, however, seems to be associated with an inferior overall survival in some subgroups.


Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 4591-4591 ◽  
Author(s):  
Alexander Claviez ◽  
Christine Mauz-Körholz ◽  
Hans-Jürgen Heidebrecht ◽  
Günther Schellong ◽  
Dieter Körholz ◽  
...  

Abstract Cancer/testis (CT) antigens are members of a large tumor-associated protein family of increasing interest because of their diagnostic and possible therapeutic implications. Only few studies have investigated CT antigen expression in Hodgkin’s lymphoma (HL) so far. Recently, immunopurification of a 25/22-kDa antigen and sequencing revealed a peptide of 14 amino acids, which corresponds to the gene product of the newly described gene family MGC27005, located on chromosome Xq26.3, now termed CT45. The antigen shows a CT antigen-like expression pattern in human tissues and is detectable by the monoclonal antibody Ki-A10 generated after immunization of mice with HL-derived cell line L428. In this study, the expression pattern of CT45 in a large number of patients with HL included in subsequent pediatric multicenter treatment protocols of the GPOH was analyzed. Immunohistochemical results of Ki-A10 staining were correlated with histological subtype, immunophenotype, clinical data and outcome. In total, 1124 children and adolescents with HL diagnosed between 1978 and 2004 were studied. Median age of the patients was 13.7 years (range, 2.2 to 19.5) and 637 patients 02(57%) were male. Classical HL (cHL) was diagnosed in 988 patients (88%) and nodular lymphocyte predominant HL (NLPHL) was seen in 136 patients (12%). The group of cHL included 683 cases of nodular sclerosis HL (NSHL), 280 cases of mixed cellularity HL (MCHL), ten cases of lymphocyte-rich cHL (LRCHL), seven cases of lymphocyte-depleted HL (LDHL) and eight cases without subclassification. Nuclear CT45 expression was found in 526 cases (47%) with striking differences among histological subtypes and unrelated to CD30, CD20 and latent EBV infection. In NLPHL, 15% of cases scored CT45 positive in contrast to 51% of cases in cHL (p<.001). Within cHL, 58% of cases with NSHL were CT45 positive compared to 36% of cases with MCHL (p<.001). Aggressive histological variants of cHL (NSHL Bennett 2, LDHL) stained positive for CT45 in 62% of cases in comparison to 49% of other subtypes (p=.002). CT45 expression was associated with stage (p<.001), presence of B symptoms (p=.026), extranodal disease (p=.009) and allocation to treatment group (TG, p<.001). Fewer patients from TG1 (localized disease) were CT45 positive than patients from TG2/3 (intermediate and advanced disease; 38% vs. 53%, p<.001). With a median follow-up of 5.6 years, 97% of patients are alive. No significant differences were observed for overall survival, failure-free survival and event-free survival with respect to CT45 status. CT45 expression, which is restricted to neoplastic cells in HL, is found in a significant number of children and adolescents with HL, especially in cases of NSHL, aggressive histological subtypes and advanced disease. Due to effective polychemotherapy with or without low-dose radiotherapy, CT45 status did not emerge as an adverse prognostic factor in children and adolescents with HL in this series.


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 745-745 ◽  
Author(s):  
Hans Knecht ◽  
Narisorn Kongruttanachok ◽  
Bassem Sawan ◽  
Zelda Lichtensztejn ◽  
Daniel Lichtensztejn ◽  
...  

Abstract Abstract 745 Introduction: Innovative 3D telomere q-FISH allows a mechanistic understanding of the transition from the mononuclear Hodgkin (H) to the multinuclear Reed-Sternberg (RS) cell in in Hodgkin's lymphoma (HL) derived cell lines and diagnostic patient biopsies (Leukemia. 2009; 23:565-573). In RS-cells the telomere protecting shelterin complex appears to be disrupted and deregulation of DNA repair mechanisms is observed. These changes occur in both, classical EBV negative and EBV-associated, LMP1 expressing HL (Lab Invest. 2010; 90:611-619). However, it is not known whether the 3D telomere profile at diagnostic biopsy is different in patients entering rapid remission after initiation of standard chemotherapy (ABVD) compared to that-one of patients with relapsing or refractory disease. In order to answer this question we analyzed by 3D telomere q-FISH diagnostic biopsies of HL patients entering rapid complete remission and compared them to diagnostic biopsies of patients with relapsing or refractory disease. Patients and methods: Rapid remission group (after 1–4 cycles of ABVD): 7 diagnostic biopsies of 7 patients, 19–57 years old, 5 male, 3 LMP1 expressing, 4 nodular sclerosis subtype, 3 mixed cellularity subtype, stages IA, IIA, IIIA × 2, IIIB x2, IVA. Relapse group: 7 diagnostic biopsies of 4 patients, 40–77 years old, 2 male, 1 LMP1 expressing, 3 nodular sclerosis subtype, 1 mixed cellularity subtype, stages IIA bulky, IIIB × 2, IVB; first remission after 6–8 cycles of ABVD in 3 patients, 1 patient died from progressive disease after 11 months. 3D telomere q-FISH was performed as described (Lab Invest. 2010; 90:611-619) and statistical analysis was performed using nested or two-way analysis of variance. Results: Bi- or multinuclear RS-cells of all patients from both groups showed a significant increase of very short telomeres and telomere aggregates when compared to the mononuclear precursor H-cells. However, most importantly, all diagnostic biopsies of the relapse group contained a very high percentage of very small telomeres, including so-called “t-stumps”, in both, H-cells (76,8 ± 11,8%) and RS-cells (87,9 ± 7,3%). Compared to the percentage of very small telomeres identified in both, H-cells (33,7 ± 9,4%) and RS-cells (54,6 ± 15,0%) of the rapid remission group, this increase is highly significant (p <0.001). Moreover, analogous findings are observed for the number of telomere aggregates. In the relapse group the average numbers of telomere aggregates per cell were 4,3 ± 2,4 aggregates per H-cell and 5,4 ± 3.0 aggregates per RS-cell, compared to 1,2 ± 0,7 aggregates per H-cell and 3,3 ± 1,1 aggregates per RS-cell in the rapid remission group. Discussion: The 3D nuclear telomere organization of H- and RS- cells in diagnostic biopsies of relapsing or refractory HL is characterized by both, H- and RS-cells with abundant “t-stumps” and numerous telomere aggregates. Very short telomeres, including t-stumps, and telomere aggregates, both, are characteristics of aggressiveness in cancer biology (Mol Cell. 2007;28:315-327; J Cell Biochem. 2010; 109:1095-1102). Thus, H- and RS-cells of refractory or relapsing HL show significant differences in the 3D telomere dynamics already at first, diagnostic biopsy when compared to H- and RS-cells of HL entering rapid remissions. Disclosures: No relevant conflicts of interest to declare.


2009 ◽  
Vol 48 (7) ◽  
pp. 1085-1086
Author(s):  
Pasquale Niscola ◽  
Andrea Tendas ◽  
Laura Scaramucci ◽  
Stefano Fratoni ◽  
Marco Giovannini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document